Objectives: The aim of this study was to measure the tissue sodium concentration (TSC) within tumors and normal prostate in prostate cancer patients, using prostatectomy as pathological criterion standard. Materials and Methods: Fifteen patients with biopsy-proven, magnetic resonance imaging (MRI) visible, intermediate-or high-risk prostate cancer underwent a dedicated research sodium MRI, before treatment with radical prostatectomy. All participants signed written informed consent for this institutional review board-approved prospective study. 3 T MRI acquired using a dedicated multinuclear clamshell transmit coil and a bespoke dual-tuned 1 H/ 23 Na endorectal receive coil, with intracellular-sodium imaging acquired using inversion recovery sequences; a phantom-based calibration enabled quantitative sodium maps. Regions of interest were defined for normal peripheral zone (PZ) and transition zone (TZ) and tumor regions, referenced from histopathology maps. A 1-way analysis of variance compared normal and tumor tissue, using Tukey test for multiple comparisons. Results: Two patients were excluded due to artifact; software error resulted in 1 further intracellular-sodium failure. Fifteen tumors were detected (13 PZ, 2 TZ) in 13 patients: Gleason 3 + 3 (n = 1), 3 + 4 (6), 3 + 5 (2), 4 + 3 (5), 4 + 5 (1). Both mean TSC and intracellular-sodium were significantly higher in normal PZ (39.2 and 17.5 mmol/L, respectively) versus normal TZ (32.9 and 14.7; P < 0.001 and P = 0.02). Mean TSC in PZ tumor (45.0 mmol/L) was significantly higher than both normal PZ and TZ tissue (P < 0.001). Intracellular sodium in PZ tumors (19.9 mmol/L) was significantly higher than normal TZ (P < 0.001) but not normal PZ (P = 0.05). Mean TSC and intracellular-sodium was lower in Gleason ≤3 + 4 tumors (44.4 and 19.5 mmol/L, respectively) versus ≥4 + 3 (45.6 and 20.2), but this was not significant (P = 0.19 and P = 0.29). Conclusions: Tissue sodium concentration and intracellular sodium concentrations of prostate tumors were quantified, with PZ tumors demonstrating a significantly increased TSC.
1
H/ 23 Na endorectal receive coil, with intracellular-sodium imaging acquired using inversion recovery sequences; a phantom-based calibration enabled quantitative sodium maps. Regions of interest were defined for normal peripheral zone (PZ) and transition zone (TZ) and tumor regions, referenced from histopathology maps. A 1-way analysis of variance compared normal and tumor tissue, using Tukey test for multiple comparisons. Results: Two patients were excluded due to artifact; software error resulted in 1 further intracellular-sodium failure. Fifteen tumors were detected (13 PZ, 2 TZ) in 13 patients: Gleason 3 + 3 (n = 1), 3 + 4 (6), 3 + 5 (2), 4 + 3 (5), 4 + 5 (1) . Both mean TSC and intracellular-sodium were significantly higher in normal PZ (39.2 and 17.5 mmol/L, respectively) versus normal TZ (32.9 and 14.7; P < 0.001 and P = 0.02). Mean TSC in PZ tumor (45.0 mmol/L) was significantly higher than both normal PZ and TZ tissue (P < 0.001). Intracellular sodium in PZ tumors (19.9 mmol/L) was significantly higher than normal TZ (P < 0.001) but not normal PZ (P = 0.05). Mean TSC and intracellular-sodium was lower in Gleason ≤3 + 4 tumors (44.4 and 19.5 mmol/L, respectively) versus ≥4 + 3 (45.6 and 20.2), but this was not significant (P = 0.19 and P = 0.29). Conclusions: Tissue sodium concentration and intracellular sodium concentrations of prostate tumors were quantified, with PZ tumors demonstrating a significantly increased TSC.
Key Words: sodium, magnetic resonance imaging, prostate cancer, molecular imaging (Invest Radiol 2018;53: 450-456) P rostate cancer is the commonest noncutaneous malignancy in men worldwide, and its incidence is expected to double by 2030, in part due to an aging global population. 1, 2 Multiparametric magnetic resonance imaging of the prostate has become an established diagnostic tool for prostate cancer, and although it is routinely used for lesion detection, sensitivity and specificity can vary widely from 53% to 100% and 32% to 97%, respectively; specificity can be as low as 47% when lesions of indeterminate radiological suspicion are considered. [3] [4] [5] Therefore, improved imaging for characterization and risk stratification would be beneficial given concerns about overdiagnosis and overtreatment of indolent disease in the era of widespread prostate-specific antigen (PSA) testing. 6 Anatomical T2-weighted imaging is limited by the nonspecific nature of low signal intensity findings in the peripheral zone (PZ). 7 Although T2-weighted imaging is considered the key sequence in the transition zone (TZ), the TZ remains a difficult part of the gland to interpret. 8, 9 Furthermore, morphological imaging cannot accurately grade tumors, and in the absence of validated biomarkers, only functional imaging offers the potential for noninvasive lesion characterization and improved detection. Previous studies have shown that apparent diffusion coefficient (ADC) values derived from diffusion-weighted imaging (DWI) correlate to prostate cancer aggressiveness. [10] [11] [12] However, restricted diffusion is not specific to tumors and can be seen within highly cellular nodules of benign prostate hyperplasia, stromal tissue, and in prostatic abscesses. Indeed, the most recent version of the prostate imaging reporting and data system (PI-RADS) guidelines strongly supports the continued development of novel MRI methodologies for assessment of prostate cancer.
Standard clinical 1 H-MRI provides information about the distribution of water molecules, but MRI can be used to detect several nuclei other than hydrogen, thus allowing for other physical and metabolic processes to be studied in the human body. One such example is sodium ( 23 Na), which produces the second highest signal on MRI from the nuclei detectable in biological tissues. However, the MRI sensitivity for sodium is approximately 9.2% of protons, and the sodium concentration in vivo is approximately 2000 times lower than that of protons, resulting in signal-to-noise ratios (SNRs) up to 20,000 times lower than prostate are published, with only 3 studies assessing healthy volunteers and a further study investigating 3 patients with biopsy-proven prostate cancer, without quantifying tumor sodium concentration. [15] [16] [17] [18] Therefore, the aim of this study was to measure the tissue sodium concentration (TSC) within tumors and normal prostate in cancer patients, using prostatectomy as the pathological criterion standard.
MATERIALS AND METHODS
The local institutional review board and ethics committee granted approval for this prospective study (CUH/16/EE/0205), with all participants signing written informed consent. Fifteen patients with biopsyproven, MRI visible (PI-RADS score 4 or 5 lesions on prior diagnostic prostate MRI), intermediate-or high-risk prostate cancer underwent a dedicated research sodium MRI between May 2016 and August 2017, before treatment with radical prostatectomy. Exclusion criteria were previous treatment for prostate cancer, a clinical contraindication to MRI, or renal impairment (glomerular filtration rate <30 mL/min).
Magnetic Resonance Imaging
All phantom experiments and clinical imaging were performed on a clinical 3 T system (GE MR750; GE Healthcare, Waukesha, WI) using a dedicated multinuclear clamshell transmit coil with a large bandwidth (GE Healthcare, Waukesha, WI) and a bespoke dual-tuned For intracellular-weighted imaging, the sodium sequence was repeated with the addition of a 5.6-millisecond adiabatic inversion pulse with inversion time (TI) of 30 milliseconds, TR of 120-210 milliseconds, resolution and FOV as before, 10 NEX, 5390 total readouts, and 11 to 19 minutes' acquisition duration. The variation in TR was due to restrictions imposed by the Specific Absorption Rate (SAR) limit and varied between patients due to differences in weight, which ranged from 65 to 109 kg (mean weight, 83.5 ± 12.7 kg). For the inversion recovery sodium imaging, TR and therefore total acquisition duration was varied due to SAR limitations. Sodium images were corrected for receive sensitivity by dividing the images by a heavily smoothed duplicate image (Gaussian kernel, sigma = 5 22 ; Fig. 1 ). A phantom replacement method was used to create a calibration curve against 5 NaCl in 4% agar phantoms varying between 7 and 160 mM/L NaCl, and this was applied to the in vivo data to create quantitative sodium maps. 23 
Histopathology Assessment
Prostatectomy specimens were fixed in formalin and oriented by the location of the seminal vesicles, posterior surface of the prostate, and by the position of the urethra. The apical cone was amputated and sliced into 4-mm sections from left to right; the remaining gland was cut transversely into 5-mm whole-mount parallel slices in the horizontal plane from inferior to superior. Representative 5-μm microtome slides were processed from each 5-mm whole-mount slices for histopathological analysis. Tumor was outlined on hematoxylin and eosin-stained sections from each slice by an experienced uropathologist specializing in prostate cancer.
Correlation of Histopathology to Imaging
A radiologist with 7 years of experience reporting clinical prostate MRI used the histopathological tumor maps in conjunction with the available diagnostic MRI data sets to outline peripheral zone (PZ), transition zone (TZ), and tumor. The tumor location from histopathological slides was used to manually delineate an ROI on the T2-weighted anatomical image acquired using the endorectal coil. Regions of interest of a minimum volume of 0.5 cm 3 were additionally drawn on at least 3 consecutive slices for normal TZ and PZ, with care taken to avoid partial volume effects from the urethra, bladder, seminal vesicles, extraprostatic tissue, and at the zonal interfaces. Separately, to assess whether the reduced SNR in the anterior gland affected estimates of sodium concentration, ROIs in all patients were drawn in the anterior half and posterior half of the TZ. Regions of interest based on these outlines were then copied to the colocalized sodium images using OsiriX 8.5.1 (Pixmeo SARL, Bernex, Switzerland).
Statistics
A balanced 1-way analysis of variance was performed to compare the results from each patient for normal PZ, normal TZ, and tumor ROIs, using Tukey test for multiple comparisons. A 2-sided Wilcoxon rank sum test was used to assess for differences in sodium values between tumor grades. A P value of less than 0.05 was considered statistically significant.
RESULTS
Magnetic resonance imaging was acquired without complications, and all patients proceeded to prostatectomy. The 15 participants had a median age of 59.5 years (mean, 60.7; range, 48-73 years) and a median prebiopsy serum PSA of 8.4 ng/mL (mean, 9.79; interquartile range, 6.125-11.6 ng/mL; Table 1 ). The average time between diagnostic prostate biopsy and the study MRI was 89.6 days (range, 43-179 days). Eight patients underwent MRI scanning on the day of surgery; the mean time from MRI to surgery was 5 days (median, 0; range, 0-31 days). The total sodium MRI time ranged from 18 to 26 minutes. The whole examination time including proton scans and coil insertion was on average of 37 minutes (range, 35-47 minutes).
Seventeen tumors were detected in the 15 patients imaged, with final pathology of Gleason score 3 + 3 (n = 1), 3 + 4 (n = 7), 3 + 5 (n = 2), 4 + 3 (n = 5), and 4 + 5 (n = 2). The mean tumor size at final Table 2 , Fig. 3 ). Overall, 11/13 peripheral zone tumors had a higher TSC than the corresponding normal PZ on the contralateral side of the gland. The mean PZ tumor TSC was significantly higher than both the normal PZ TSC (P < 0.001) and the normal TZ TSC (P < 0.001; Fig. 4) . Two of the 15 tumors were located in the TZ; their mean TSC was 30.6 and 30.8 mmol/L, which was slightly lower than the TSC in the adjacent normal TZ.
The mean intracellular-weighted sodium was also significantly higher in the normal PZ (17.5 mmol/L; range, 10.2-21.4) than in the normal TZ (14.7 mmol/L; range, 7.9-18.0; P = 0.02). The mean intracellular-weighted sodium for all tumors was 18.7 mmol/L and for PZ tumors 19.9 mmol/L (range, 15.8-22.3). Overall 9/12 PZ tumors had higher intracellular sodium content than the adjacent normal PZ (borderline significant, P = 0.05), with PZ tumor tissue having a significantly higher intracellular sodium than normal TZ (P < 0.001; Fig. 5 ). Both TZ lesions had slightly higher intracellular sodium values than the normal TZ (Table 3) .
Regional assessment of the differences in signal between the anterior and posterior gland showed a significant variation. The mean TSC value in the anterior TZ was 30. 
DISCUSSION
This study demonstrates the ability of MRI to quantify TSC and intracellular sodium concentration in both tumors and normal prostate tissue. Tissue sodium concentration has previously been quantified in the normal PZ and TZ of both volunteers and patients. Here we developed sodium MRI at a higher spatial resolution than previously achieved and quantify tissue and intracellular sodium concentrations within prostate tumors for the first time.
The total TSC was significantly higher in tumors than in normal tissue, and the intracellular sodium was higher in tumors than in normal TZ. We found a significant difference between intracellular sodium in normal PZ and TZ (17.5 and 14.7 mmol/L). The values measured are within the expected range for other tissues, with intracellular sodium concentrations previously reported to be approximately 10 to 15 mmol/L. 13, 24, 25 It is possible that the higher values found in the normal PZ reflect differences in cellularity and sodium gradients across the membrane between the tissues, within more metabolically active PZ cells. 15 Previous studies support our findings of a higher TSC in normal PZ compared with TZ. 15, 16, 18 These studies show a wide range in TSC within normal PZ (40.4-70.5 mmol/L) and within TZ (28.3-60.2 mmol/L). We found the mean concentrations in the PZ and TZ of our study population to be at the lower end of this range (39.2 and 32.9 mmol/L, respectively), which may relate to technical variations, differences in spatial resolution, or the effects of partial voluming.
Physiologically, extracellular sodium concentration (140-150 mmol/L) is an order of magnitude higher than intracellular sodium concentration; however, the extracellular volume fraction (including vessels) accounts for only approximately 20% of total tissue volume. 13, 25 The higher relative contribution of intracellular sodium to the total sodium measurement would therefore give an expected TSC in the range of 36 to 42 mmol/L and therefore supports our measurements. The differences in TSC levels between normal PZ and TZ is likely due to the differing composition of their respective tissues, with the normal PZ having a glandular structure with an extensive duct system, a relatively loose stroma, and a larger extracellular space. [26] [27] [28] Furthermore, Hausmann et al 15 showed that TSC measurements of the normal PZ and TZ correlated to their respective ADC measurements on DWI; the young age of the volunteers imaged (26-34 years) may limit the applicability of the findings in the TZ of this population to men with prostate cancer who are usually older, but the results support a relationship between the increased extracellular space of the glandular PZ (and free diffusion of water) and higher concentrations of sodium in the normal PZ. Of note, we found a small but significant difference in TSC between the posterior and anterior TZ, which is likely to relate to reducing SNR with increasing distance from the coil.
In healthy tissues, the large concentration gradient between intracellular and extracellular sodium is maintained by several transporters and pumps, the most important being Na + /K + -ATPase. 29 Therefore, a potential advantage of sodium imaging over proton MRI is the ability to provide functional information relating to tissue viability, cell membrane integrity, and energetic status of the cellular environment. In tumors, changes in TSC may reflect changes in intracellular and extracellular sodium or both, as well as changes in the size of each compartment. Increases in cell density will reduce the extravascular extracellular space, and TSC will be weighted toward the low concentration of sodium from the intracellular compartment. Conversely, an increased interstitial space will increase the extracellular weighting of the TSC measurement. Intracellular sodium in tumor cells may rise when demand for ATP exceeds production, limiting the ability of the Na + /K + -pump to maintain the sodium gradient, or due to overactivity of the Na + /K + -pump to compensate for the low pH of the tumor microenvironment induced by hypoxia and increased lactate. 13, 30, 31 Tissue sodium concentration has been shown to be elevated in several tumor types and has the potential to demonstrate treatment response in a number of conditions such as breast cancer, 32 murine models of prostate cancer, 33 and successful ablation of uterine fibroids. 34 We found a significantly higher TSC in PZ tumors compared with both normal PZ and normal TZ. This implies that the change in sodium concentration in tumors reflects more than a simple change in cellularity. Prostate tumors have a higher cell density than the normal PZ, typically seen as low ADC values. Given that intracellular sodium is significantly lower than extracellular sodium, cellular changes alone would lead to a reduction rather than an increase in TSC, by increasing the percentage contribution of intracellular sodium at the expense of a reduced extracellular space. Intracellular sodium in PZ tumors was higher than in normal PZ and TZ, with the difference being significant compared with the TZ and borderline significant compared with the PZ; this change in intracellular sodium could reflect changes in cellularity alone. Taken together, these results suggest that there is an increase in extracellular sodium concentration in PZ tumors. Interestingly, the 2 TZ tumors had lower TSCs compared with the PZ tumors, which may be partly explained by the drop-off in SNR with increasing distance from the coil: PZ tumors are unlikely to be affected due to their relative proximity to the receive coil. However, the lower sodium values in these TZ tumors relative to normal TZ implies that this is a genuine finding and indicates a different sodium environment in TZ and PZ tumors. Indeed, TZ tumors have morphological differences compared with PZ tumors, with well-differentiated glands of variable size and are lined by columnar cells with a clear cell histological pattern. 35, 36 However, the number of TZ lesions in our study was small, and further investigation is warranted.
There may be several potential applications for sodium MRI in prostate cancer, including localization and characterization of the primary tumor, monitoring treatment response to oncological agents, and detecting local recurrence following radical therapy. Furthermore, any treatment that causes cell death or loss of membrane integrity, such as the many focal ablative therapy techniques that are being trialed in prostate cancer, could potential be monitored with sodium MRI. The detection of sodium signal in vivo remains challenging and improvements in hardware and software and/or increasing magnet strength are needed to help improve SNR and resolution and reduce acquisition times and make this promising technique more clinically available. Importantly, there is increasing scientific interest in the acquisition of hyperpolarised carbon-13 MRI, particularly in the prostate 37 ; given the similar resonance frequency of the carbon and sodium nuclei and the similar acquisition strategies required, development of 13 C hardware and software will directly impact on the ability to image sodium and increase the availability of equipment, sequences, and MRI physics expertise.
Our study has some limitations. The total number of tumors was relatively small, and only 2 TZ tumors were included. The selection bias of patients undergoing prostatectomy while affording definitive histology limits the ability to differentiate grade type in this cohort, with an overrepresentation of Gleason 3 + 4 and 4 + 3 disease and underrepresentation of higher-grade and lower-grade Gleason 3 + 3 disease. Sodium imaging was performed after anatomical T2 imaging and theoretically interim bladder filling could affect prostate position and lead to mismatch between the sequences. Although some studies report that a large bladder volume can displace the prostate, 38,39 others have reported minimal or no effect on position due to the relatively low, fixed position of the prostate in the pelvis. 40, 41 The study subjects were selected on the basis of lesions detectable on standard clinical prostate multiparametric magnetic resonance imaging, and therefore the added value of the technique for detecting lesions de novo was not assessed. We did not acquire standard multiparametric MRI sequences of DWI and dynamic contrast-enhanced due to time restraints, and although diagnostic MRI had been performed previously, these were acquired with differing protocols. Further work is needed to directly compare sodium imaging to standard proton sequences and to assess the incremental value.
In conclusion, we successfully quantified the tissue and intracellular sodium concentrations of prostate tumors in vivo, demonstrating a significant increase in TSC within PZ tumors. Sodium MRI may be developed as a new, noninvasive, functional imaging technique in the management of patients with prostate cancer.
